Subscribe to Here’s the Deal, our politics
newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
By Matthew Perrone, Associated Press
The Food and Drug Administration gave clinics three years to show that their questionable treatments were safe and worked. But today none of the clinics have won FDA approval and there are more businesses than before selling the treatments for…
By Matthew Perrone, Lauran Neergaard, Mike Stobbe, Associated Press
The FDA on Wednesday signed off on such shots as a way to shore up protection in those groups. This is not a done deal yet: The CDC has yet to weigh in on who it believes should get boosters…
By Matthew Perrone, Lauren Neergaard, Associated Press
An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it approved the extra doses for those who are 65 or older or run a high risk of severe…
By Lauran Neergaard, Matthew Perrone, Associated Press, Associated Press
An influential federal advisory panel has overwhelmingly rejected a plan to give Pfizer booster shots against COVID-19 to most Americans, but it endorsed the extra shots for those who are 65 or older or run a high risk of severe…
By Lauran Neergaard, Matthew Perrone, Associated Press
An international group of scientists is arguing the average person doesn't need a COVID-19 booster yet — an opinion that highlights the intense scientific divide over the question.
By Lauren Neergaard, Associated Press
Dr. Peter Marks tells The Associated Press he is "very, very hopeful" that vaccinations for 5- to 11-year-olds will be underway by year's end. One company, Pfizer, is expected to turn over its study results by the end of September.
Parents, politicians and anti-tobacco advocates have pressured the FDA for years to ban Juul's high-nicotine devices, which many blame for the recent spike in underage vaping.
By Linda A. Johnson, Associated Press
Wednesday's move by the Food and Drug Administration will allow pharmacists to automatically substitute the cheaper version, just as they do with generic pills for other kinds of drugs.
Dr. Janet Woodcock announced the extraordinary step via Twitter. It's the latest fallout over last month's approval of Aduhelm, an expensive and unproven therapy that the agency OK'd against the advice of its own outside experts.
By Lauran Neergaard, Associated Press
The company said Thursday that another shot could dramatically boost immunity and maybe help ward off the latest worrisome coronavirus mutant.
Support Provided By: